Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 68Leukemia 56Myelodysplastic Syndromes 53Lymphoma 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Lymphoma, Non-Hodgkin 43Multiple Myeloma 40Hodgkin Disease 39Leukemia, Lymphocytic, Chronic, B-Cell 35Congenital Abnormalities 30Lymphoma, Follicular 28Lymphoma, Large B-Cell, Diffuse 27Lymphoma, Mantle-Cell 26Neoplasms, Plasma Cell 25Lymphoma, B-Cell, Marginal Zone 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Burkitt Lymphoma 23Myeloproliferative Disorders 22Lymphoma, Large-Cell, Immunoblastic 22Leukemia, Myelomonocytic, Chronic 22Blast Crisis 22Leukemia, Myeloid, Chronic-Phase 21Leukemia, Myeloid, Accelerated Phase 21Primary Myelofibrosis 19Lymphoma, T-Cell, Cutaneous 15Hematologic Neoplasms 15Graft vs Host Disease 15Dendritic Cell Sarcoma, Interdigitating 14Anemia, Refractory, with Excess of Blasts 14Waldenstrom Macroglobulinemia 13

Interventions

Bortezomib 3fludarabine 2Tacrolimus 2Cyclophosphamide 2ofatumumab 1fludarabine phosphate 1daratumumab 1birtamimab 1Zoledronic Acid 1Whole-Body Irradiation 1Vorinostat 1Thalidomide 1Stem Cell Transplantation 1Plasma Exchange 1Mycophenolic Acid 1Melphalan 1Lenalidomide 1KW-2478 1Hsp90 inhibitor KU757 1Etoposide 1Doxorubicin 1Dexamethasone 1Denosumab 1Cisplatin 1Calcium Dobesilate 1Busulfan 1Alemtuzumab 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Paraproteinemias × Busulfan × Clear all
NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡